Goodwin Advises QuantumCell ApS on Entering Out-Licensing and Collaboration Agreement With AlzeCure Pharma for Over $2.2 Billion
August 07, 2026
August 07, 2026
BOSTON, Massachusetts, Aug. 7 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises QuantumCell ApS on Entering Out-Licensing and Collaboration Agreement With AlzeCure Pharma for Over $2.2 Billion
*
The Life Sciences team advised QuantumCell ApS on entering into a licensing and collaboration agreement with AlzeCure Pharma AB ("AlzeCure"), which develops small-molecule drug candidates . . .
* * *
Goodwin Advises QuantumCell ApS on Entering Out-Licensing and Collaboration Agreement With AlzeCure Pharma for Over $2.2 Billion
*
The Life Sciences team advised QuantumCell ApS on entering into a licensing and collaboration agreement with AlzeCure Pharma AB ("AlzeCure"), which develops small-molecule drug candidates . . .